View drug registration information details.

Items	Registration information
ID	539
No	539
Brand Name	LEVOFLOXACIN KABI
Ingredients	LEVOFLOXACIN HEMIHYDRATE EQ.TO LEVOFLOXACIN 500 MG/100 ML
Dosage Form	SOLUTION FOR INFUSION
Primary Packaging	BOTTLE
Storage	DO NOT STORE ABOVE 30C, PROTECT FROM LIGHT
Shelf Life	3 YEARS
Pack Size	BOX OF 100 ML/BOTTLE
Dispensing Category	PRESCRIPTION
ATC Classification	J01MA12
Pharmaceutical Class	ANTIBACTERIA
Indications	COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SOFT TISSUE INFECTION, ACUTE BACTERIAL SINUSITIS, ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS, CHRONIC BACTERIAL PROSTATITIS, PYELONEPHRITISAND COMPLICATED URINARY TRACT INFECTION, INHALATION ANTHRAX
Contraindications	HYPERSENSITIVITY, PATIENT WITH EPILEPSY, HISTORY OF TENDON DISORDER RELATED TO FLUOROQUINOLONE ADMINISTRATION, UNDER 18 YEARS OLD, DURING PREGNANCY, IN BREAST-FEEDING WOMEN
Side Effects	INSOMNIA, HEADACHE, DIZZINESS, DIARRHEA, VOMITING, NAUSEA, HEPATIC ENZYME INCREASED
Unit Price
EDL	Yes
Description	TRANSPARENT SOLUTION WITH PALE YELLOWISH, CONTAINED IN 100 ML SEALED TRANSPARENT NEUTRAL GLASS BOTTLE
Note
License Owner	DKSH LAOS COMPANY LIMITED
Manufacturer	FRESENIUS KABI VIETNAM JOINT STOCK COMPANY
Country	VIETNAM
Import Registration No	VD-29316-18
Import Registration Date	2018-02-22
Activity	CERTIFICATE RELEASED
Applied Date	2021-12-03
FDD Registration No	04 I 5467/23
FDD Registration Date	2023-04-11
Expiry Date	2026-04-10

Back to drug list